Catalyst Wire Dossier Catalyst Wire Dossier

DCVC H1 HA mRNA-LNP

mRNA-LNP influenza vaccine encoding H1 hemagglutinin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCVC H1 HA mRNA-LNP, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults [Phase 1]

See pricing